BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
28 results:

  • 1. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types.
    Bartels S; Grote I; Wagner M; Boog J; Schipper E; Reineke-Plaass T; Kreipe H; Lehmann U
    Cancer Med; 2023 Aug; 12(16):16707-16715. PubMed ID: 37376830
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An exploration of gastric cancer with heterogeneous mismatch repair status.
    Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y
    Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of PD-1 in Tumor Cells is Associated with Shorter Survival in Non-metastatic Intestinal-type gastric Adenocarcinoma.
    Namvar N; Montazer M; Ahmadvand S; Sadeghian B; Ghaderi A
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):600-615. PubMed ID: 36640052
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Microsatellite instability in gastric cancer is a predictor of a favorable prognosis].
    Danilova NV; Chayka AV; Khomyakov VM; Oleynikova NA; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(6):5-15. PubMed ID: 36469712
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
    Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
    World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High FN1 expression correlates with gastric cancer progression.
    Li J; Chen C; Chen B; Guo T
    Pathol Res Pract; 2022 Nov; 239():154179. PubMed ID: 36274380
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
    Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
    Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
    Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
    BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
    Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
    Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
    Sahin I; Saat H
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
    [No Abstract]    [Full Text] [Related]  

  • 11. Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.
    Ying J; Yang L; Yin JC; Xia G; Xing M; Chen X; Pang J; Wu Y; Bao H; Wu X; Shao Y; Zhu L; Cheng X
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34479923
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data.
    Li F; Li J; Yu J; Pan T; Yu B; Sang Q; Dai W; Hou J; Yan C; Zang M; Zhu Z; Su L; Li YY; Liu B
    EBioMedicine; 2021 Jul; 69():103436. PubMed ID: 34157484
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemical Expression Pattern of MLH1, MSH2, msh6, and PMS2 in Tumor Specimen of Iranian gastric Carcinoma Patients.
    Salari S; Ghadyani M; Karimi M; Mortezazadeh M; Vahedifard F
    J Gastrointest Cancer; 2022 Mar; 53(1):192-196. PubMed ID: 33411254
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Expression level and prognostic value of PD-L1 in microsatellite instability-high gastric cancer].
    Wang XY; Hu YJ; Dong K; Zhao C; Huang XZ; Lian SY; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1114-1119. PubMed ID: 33152814
    [No Abstract]    [Full Text] [Related]  

  • 16. Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray.
    Zhao C; Feng Z; He H; Zang D; Du H; Huang H; Du Y; He J; Zhou Y; Nie Y
    PLoS One; 2020; 15(10):e0238836. PubMed ID: 33095797
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
    Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of mismatch repair deficiency in patients with advanced gastric cancer, treated by surgery and adjuvant 5-fluorouracil and leucovorin chemoradiotherapy.
    Kim SM; An JY; Byeon SJ; Lee J; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S
    Eur J Surg Oncol; 2020 Jan; 46(1):189-194. PubMed ID: 31500870
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer.
    Hirotsu Y; Mochizuki H; Amemiya K; Ohyama H; Yoshimura D; Amano H; Miura Y; Ashizawa H; Nakagomi K; Takaoka S; Hosoda K; Suzuki Y; Oyama T; Hada M; Kojima Y; Omata M
    Med Oncol; 2019 Jan; 36(3):23. PubMed ID: 30694393
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma.
    Patil PA; Blakely AM; Lombardo KA; Machan JT; Miner TJ; Wang LJ; Marwaha AS; Matoso A
    Histopathology; 2018 Jul; 73(1):124-136. PubMed ID: 29489025
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.